Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report) rose 5.7% on Monday after an insider bought additional shares in the company. The stock traded as high as $22.10 and last traded at $21.97. Approximately 2,810,538 shares traded hands during mid-day trading, a decline of 59% from the average daily volume of 6,811,084 shares. […]
Shares of Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report) rose 5.7% on Monday after an insider bought additional shares in the company. The company traded as high as $22.10 and last traded at $21.97. Approximately 2,810,538 shares changed hands during trading, a decline of 59% from the average daily volume of 6,811,084 […]
Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report) insider Soleil Boughton sold 2,502 shares of the company’s stock in a transaction that occurred on Tuesday, May 28th. The stock was sold at an average price of $17.33, for a total transaction of $43,359.66. Following the transaction, the insider now directly owns 156,855 shares […]
Hims & Hers Health (NYSE:HIMS) Reaches New 52-Week High at $21 16 dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.
Hims & Hers Health (NYSE:HIMS – Free Report) had its price objective hoisted by Canaccord Genuity Group from $20.00 to $24.00 in a research report sent to investors on Wednesday, Benzinga reports. The brokerage currently has a buy rating on the stock. HIMS has been the topic of several other research reports. Leerink Partnrs reiterated […]